Article
New formula, cutoff proposed for RCC staging
Anaheim, CA-The 1997 TNM staging system for renal cell carcinoma is coming under increasing scrutiny from a number of institutions, including UCLA, where researchers have not only called into question the discriminatory power of the system but have gone a step further by proposing an alternative system that they feel offers more accurate prognoses.
Related Videos
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
An Overview Of Pembrolizumab for High-Risk BCG Unresponsive NMIBC
Case 2: A 63-Year-Old Man With Recurrent HSPC
Comorbidities and Adherence: Tailoring mHSPC Treatment
FDA-Approved Options for High-Risk BCG-Unresponsive NMIBC
De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Alternative treatments and patient communication for genitourinary syndrome of menopause
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Related Content
